Diagnostic accuracy

How Accurate Is — a Biopsy?

A biopsy is the most reliable test available for diagnosing cancer. Accuracy is not uniform — it depends on how the biopsy was done, where the sample was taken, and whether enough tissue was collected. Knowing what affects the result helps you ask the right questions.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

False positives are rare — When a biopsy says cancer is present, it is almost always correct.
Sampling error is the main risk — A negative result does not always rule out cancer — the needle can miss the abnormal area.
Image guidance improves accuracy — Biopsies directed by ultrasound or CT are more reliable than those done by feel alone.
Context always matters — Your team reads your biopsy result alongside imaging and examination findings, not in isolation.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

A biopsy is the most accurate single test for diagnosing cancer. When performed with imaging guidance and adequate sampling, it reliably confirms or rules out cancer for most accessible tumours. The main limitation is not false positives — it is sampling error, where the needle misses the abnormal area. Your result is always read alongside your imaging and clinical picture.

How accurate is a biopsy?

A biopsy is the diagnostic gold standard for cancer — the test that all other tests are measured against. When a biopsy says cancer is present, it is almost always correct. False positives are rare.

The greater limitation is false negatives, where cancer is present but the sample does not show it. This almost always happens because of sampling error: the needle collected tissue from near the right area, but not from the specific part containing the cancer cells.

Image-guided core needle biopsies — directed by ultrasound or CT — achieve substantially higher accuracy than biopsies done by feel alone. NCCN and ASCO guidance consistently recommends imaging guidance as the preferred approach for accessible solid tumours, citing it as more accurate than palpation-guided techniques.

What affects how accurate a biopsy is?

Whether imaging guidance (ultrasound, CT, or MRI) was used to direct the needle
How many tissue samples were taken from the same lesion
The size of the lesion — very small lesions are harder to target precisely
The depth and accessibility of the lesion in the body
Whether the sample collected was adequate — enough tissue for the pathologist to assess
The experience of the team performing and interpreting the biopsy
Whether the result matches your imaging and clinical findings

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Where is a biopsy least reliable?

Sampling error is more likely when a lesion is very small. Even a well-aimed needle may collect mostly normal tissue from around the abnormality rather than from within it.

Large tumours present a different problem. The centre of a large tumour is often necrotic — the tissue has died — and sampling there gives non-diagnostic material even though cancer is clearly present elsewhere in the mass.

Certain locations and cancer types are more technically challenging: dense sclerotic bone metastases, endoscopic biopsies of poorly visualised lesions, and deep structures such as the mediastinum or retroperitoneum. Your team will tell you if any of these limitations apply to your situation.

What do these biopsy terms mean?

False negative: A biopsy result showing no cancer when cancer is actually present. Almost always caused by sampling error rather than a laboratory mistake.
Sampling error: The needle collected tissue from the correct location, but not from the specific part containing cancer cells. The tumour was simply not in the sample.
Insufficient sample: Not enough tissue was obtained for the pathologist to assess reliably. Reported separately from a negative result and usually means a repeat biopsy is needed.
Concordant result: The biopsy result matches what the imaging and clinical findings would predict. A concordant negative is more reassuring than one that contradicts the scan.
Discordant result: The biopsy result does not match the imaging or clinical picture. A benign report from a suspicious lesion triggers a multidisciplinary review rather than simple reassurance.

What happens when a biopsy result does not match the clinical picture?

Concordance check
Your oncologist compares the biopsy report against your imaging and examination findings to assess whether the result makes clinical sense.
Multidisciplinary discussion
If there is a discrepancy, the case goes to a tumour board meeting where radiologists, pathologists and oncologists review it together.
Pathology review
The original slides may be re-examined, sometimes by a second pathologist, to confirm or revise the initial interpretation.
Decision on next steps
The team decides whether a repeat biopsy is needed, whether a different approach would be more reliable, or whether additional imaging would resolve the uncertainty.
Outcome communicated to you
You are told whether the original result stands, whether the diagnosis has changed, or what further investigation is planned.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

False Negatives & Accuracy

Breast Markers: ER, PR, HER2, Ki-67

IHC Markers Explained

Inadequate, Inconclusive & Repeat Biopsy

Labs, Slides, Blocks & Second Opinions

Molecular & Genomic Testing

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

Can a biopsy miss cancer even when it is done correctly?

Yes. A technically correct biopsy can still return a false negative if the needle collected tissue from the right area but not from the specific part containing the cancer cells. This is called sampling error and is the main limitation of biopsy. It is not a mistake — it is an inherent constraint of sampling a small portion of a larger lesion. This is why your result is always read alongside imaging and clinical findings, and why a discordant benign result prompts further review rather than simple reassurance.

What does a negative biopsy result actually mean?

A negative result means no cancer was found in the tissue sampled. It does not guarantee that cancer is absent in the rest of the lesion. Your team assesses whether the result is concordant — consistent with your imaging and clinical findings. A concordant negative, where the lesion looked unlikely to be cancer on imaging and the biopsy confirms this, is genuinely reassuring. A discordant negative, from a lesion that still looks suspicious on scan, is treated differently and leads to further investigation.

Is a fine needle biopsy less accurate than a core needle biopsy?

Generally, yes. Fine needle aspiration (FNAC) collects individual cells rather than a tissue core. It can identify whether cancer cells are present, but it cannot show how those cells are arranged within the tissue — information that is important for classifying certain cancers and planning treatment. Core needle biopsy preserves the tissue architecture and usually provides a more complete assessment. Your team will choose the method that suits the location of the lesion and the clinical information they need.

Why would my doctor recommend a repeat biopsy?

A repeat biopsy is usually recommended when the first sample was insufficient — not enough tissue to reach a conclusion — or when the result is discordant with the imaging. It may also be recommended if treatment is not working as expected, because tumours can change over time and a repeat biopsy may reveal new characteristics or mutations. A request for a repeat biopsy is not a sign that something went wrong; it is part of getting the diagnosis right.

How do I know whether enough tissue was taken?

Your pathology report will note whether the sample was adequate for assessment. If it was not, the report will say so explicitly — usually as an insufficient or non-diagnostic sample — and a repeat biopsy is typically arranged. If you are unsure, ask your oncologist directly whether the sample was considered adequate and whether any follow-up is planned. You are entitled to a clear answer to that question.

I still feel something is wrong after a benign biopsy. What should I do?

Tell your treating team. A continuing concern — a lump that has changed, a symptom that is not settling, imaging that still looks suspicious — is relevant information regardless of the biopsy result. Your team can assess whether the result is concordant with your current findings and whether repeat biopsy or follow-up imaging is warranted. You are not expected to simply accept a result that does not match your experience. Raising it directly is the right step.

Full index